Viking Therapeutics Inc
NASDAQ:VKTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
US |
|
Nick Scali Ltd
ASX:NCK
|
AU |
|
National Vision Holdings Inc
NASDAQ:EYE
|
US |
|
Modine Manufacturing Co
NYSE:MOD
|
US |
|
Natwest Group PLC
LSE:NWG
|
UK |
|
Luk Fook Holdings (International) Ltd
HKEX:590
|
HK |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
Prudential Financial Inc
NYSE:PRU
|
US |
|
Abbvie Inc
NYSE:ABBV
|
US |
|
Ameris Bancorp
NASDAQ:ABCB
|
US |
|
R
|
Riley Exploration Permian Inc
AMEX:REPX
|
US |
|
Fidelity National Information Services Inc
NYSE:FIS
|
US |
|
Exlservice Holdings Inc
NASDAQ:EXLS
|
US |
|
Mitsubishi Estate Co Ltd
TSE:8802
|
JP |
|
Arm Holdings PLC
NASDAQ:ARM
|
UK |
|
Intercontinental Exchange Inc
NYSE:ICE
|
US |
Wall St Price Targets
VKTX Price Targets Summary
Viking Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VKTX is 96.008 USD with a low forecast of 34.34 USD and a high forecast of 131.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VKTX's stock price target?
Price Target
96.008
USD
According to Wall Street analysts, the average 1-year price target for
VKTX is 96.008 USD with a low forecast of 34.34 USD and a high forecast of 131.25 USD.